Farther Finance Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-21
Closed -$49 3943
2024
Q1
$49 Sell
21
-3
-13% -$7 ﹤0.01% 3463
2023
Q4
$49 Buy
+24
New +$44 ﹤0.01% 3384

Other funds holding GRTS

Farther Finance Advisors's GRTS Position: Q2 2024 in Review

Farther Finance Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 21 shares — an estimated $49 sold.

Farther Finance Advisors first reported a position in GRTS in Q4 2023 and held it in 2 quarters. The position peaked at $49 in Q1 2024. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

  • Farther Finance Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Farther Finance Advisors sold 21 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $49.
  • Farther Finance Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
  • Farther Finance Advisors's Gritstone bio, Inc. Common Stock position peaked at $49 in Q1 2024.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on Farther Finance Advisors's 13F filing for Q2 2024, filed 31 Jul 2024.